Influx Healthtech Ltd (INFLUX) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 0 | NSE: INFLUX | Pharmaceuticals & Drugs | Small Cap

BSE Share Price
Not Listed

Influx Healthtech Ltd (INFLUX) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 0 | NSE: INFLUX | Pharmaceuticals & Drugs | Small Cap

DeciZen - make an informed investing decision on Influx Healthtech

Based on:

Overall Rating
Login to view analysis. Bole Toh

1. Quality


Login to view analysis.

2. Valuation


Login to view analysis.

3. Price Trend


Login to view analysis.

Influx Healthtech stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
41.92
Market Cap:
560.4 Cr.
52-wk low:
0
52-wk high:
0

Is Influx Healthtech Ltd an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of Influx Healthtech: Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Influx Healthtech Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Value Creation Index Colour Code Guide

Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 119.4%111.9%85.3%60.2%-
Value Creation
Index
7.57.05.13.3-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 59.276.1100105105
Sales YoY Gr.-28.5%31.4%4.9%-
Adj EPS 2.546.17.45.8
YoY Gr.-61.6%54.8%20.2%-
BVPS (₹) 2.56.412.619.917.8
Adj Net
Profit
4.47.211.113.413
Cash Flow from Ops. 2.96.48.97.1-
Debt/CF from Ops. 0.20.100-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NANA21%4.9%
Adj EPS NANA44.4%20.2%
BVPSNANA100.8%58.7%
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
99.689.364.645.430.6
Op. Profit
Mgn %
10.414.11719.6NAN
Net Profit
Mgn %
7.59.511.112.812.7
Debt to
Equity
0.10.100-
Working Cap
Days
076771270
Cash Conv.
Cycle
0-37220

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Influx Healthtech Ltd.

Standalone Consolidated
TTM EPS (₹) 5.8 -
TTM Sales (₹ Cr.) 105 -
BVPS (₹.) 17.8 -
Reserves (₹ Cr.) 18 -
P/BV 13.62 -
PE 41.92 -
From the Market
52 Week Low / High (₹) 0.00 / 0.00
All Time Low / High (₹) - / -
Market Cap (₹ Cr.) 560
Equity (₹ Cr.) 23.2
Face Value (₹) 10
Industry PE 40.7

Management X-Ray of Influx Healthtech:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Influx Healthtech - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Influx Healthtech

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24Mar'25
Sales5976100105
Operating Expenses 53658384
Manufacturing Costs13172328
Material Costs35404843
Employee Cost 3568
Other Costs 2455
Operating Profit 6111721
Operating Profit Margin (%) 10.4%14.1%17.0%19.6%
Other Income 0000
Interest 0000
Depreciation 0123
Exceptional Items 0000
Profit Before Tax 6101518
Tax 2345
Profit After Tax 471113
PAT Margin (%) 7.5%9.5%11.1%12.7%
Adjusted EPS (₹)2.44.06.17.4
Dividend Payout Ratio (%)0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 4122336
Share Capital 00018
Reserves 4122318
Minority Interest0000
Debt1100
Long Term Debt0000
Short Term Debt0100
Trade Payables11131429
Others Liabilities 2244
Total Liabilities 18284170

Fixed Assets

Gross Block371725
Accumulated Depreciation0136
Net Fixed Assets 361419
CWIP 0000
Investments 0000
Inventories22513
Trade Receivables10141632
Cash Equivalents 1442
Others Assets 1324
Total Assets 18284170

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity 3697
PBT 6101518
Adjustment 0123
Changes in Working Capital -2-2-5-9
Tax Paid -1-3-3-4
Cash Flow From Investing Activity -3-5-8-9
Capex -3-5-8-8
Net Investments 000-1
Others 0000
Cash Flow From Financing Activity 10-1-0
Net Proceeds from Shares 0000
Net Proceeds from Borrowing 1-0-00
Interest Paid -0-0-0-0
Dividend Paid 0000
Others 10-0-0
Net Cash Flow 120-2

Finance Ratio

PARTICULARSMar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)99.5489.3264.6445.37
ROCE (%)119.35111.8585.2660.15
Asset Turnover Ratio3.373.312.891.89
PAT to CFO Conversion(x)0.750.860.820.54
Working Capital Days
Receivable Days64585484
Inventory Days1191433
Payable Days114112104183

Influx Healthtech Ltd Stock News

Influx Healthtech Ltd FAQs

The current trading price of Influx Healthtech on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Influx Healthtech stood at ₹560.4.
The latest P/E ratio of Influx Healthtech as of 31-Dec-1969 is 41.92.
The latest P/B ratio of Influx Healthtech as of 31-Dec-1969 is 13.62.
The 52-week high of Influx Healthtech is ₹0.00 and the 52-week low is ₹0.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Influx Healthtech is ₹104.8 ( Cr.) .

About Influx Healthtech Ltd

Influx Healthtech Limited was originally incorporated on September 28, 2020 as a Private Limited Company as ‘Influx Healthtech Private Limited’ under the provisions of the Companies Act, 2013 with the Registrar of Companies, Central Registration Centre. Pursuant to a special resolution passed by the shareholders at their Extra Ordinary General Meeting held on May 09, 2022, the company was converted from a Private Limited Company to Public Limited Company. Consequently, the name of the company was changed to ‘Influx Healthtech Limited’ and a Fresh Certificate of Incorporation consequent to Conversion was issued on May 23, 2022 by the Registrar of Companies, Mumbai.

Influx Healthtech is a Mumbai-based, healthcare focused company specialising in contract manufacturing. Since its inception in 2020, the company has established as a reliable Contract Development and Manufacturing Organization (CDMO), offering specialized services to a wide range of clients across various industries. The company operates manufacturing facilities located in Thane, Maharashtra. These facilities are certified to international quality standards, including GMP (Good Manufacturing Practice), HACCP (Hazard Analysis & Critical Control Points), ISO 22000, and Halal certifications, ensuring adherence to the highest standards of safety,quality and regulatory compliance. These certifications reflect its adherence to stringent safety, quality, and regulatory compliance standards. Equipped with advanced machinery, a dedicated quality control department, and a skilled workforce, its facilities are designed to meet diverse customer needs efficiently and effectively.

Its expertise spans the production of Dietary and Nutritional Supplements, Cosmetics, Ayurvedic/Herbal Products, Veterinary Feed Supplements, Homecare Products, Active Pharmaceutical Ingredients (APIs), and finished dosage forms, including tablets, capsules, and injectables.

Business area of the company

The company is engaged in the business of manufacturing and trading of Nutra Products and other related business activities.

Products of the company

  • Dietary/Nutritional SUPPLEMENTS
  • Cosmetics
  • Ayurvedic / Herbal
  • Veterinary feeds
  • Homecare

Awards and recognition

  • 2017: Rotary Vocation Excellence Award 2017-18.
  • 2017: Best Third-Party Manufacturing company sports and Nutrition.
  • 2018: Most Promising Nutraceutical and Herbal Products Manufacture.
  • 2018: Most Promising Nutraceutical and Herbal Product Manufacturer of the year 
  • 2019: Best Nutaceutical Manufacturer to Dr. Munir Chandniwala, Managing Director of the Company.
  • 2023: Best Rotarian of the year 22-23.

History and milestones

  • 2020: Incorporation of the Company as a Private Limited Company with the name of ‘Influx Healthtech Private Limited’.
  • 2021: Addition in Main Object of a new segment of beauty and cosmetics products, personal care and disinfectant products.
  • 2022: Converted to Public Limited Company – consequently the name of the company was changed to ‘Influx Healthtech Limited’.

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×